U.S. Stem Cell, Inc. USRM
On Wednesday morning, we followed up with USRM after tracking it over a 289% rip subsequent to our alert on the play on February 27th. The stock had come down quite a bit off of those highs, and started to take on the appearance of a possible bottom-play. We mentioned the need to “return to monitoring this play more closely on the chance that it could be gearing up for another run.“
It did find its bottom and it most certainly was gearing up for another run, which took up the entirety of yesterday’s session. The stock traded in a range from .0181 to .03, for a solid intraday rip of 66%, nearly all of which was held into a strong close .0289.
That type of blatantly bullish activity warrants continued close observation of USRM as we close out the week.
Tesla, Inc. TSLA – Options Update
Just yesterday, we identified TSLA as being ripe for a recovery, citing the TSLA 04/07 $270-277.50 Calls as our targets of interest. It was another solid options trading idea for us, with every single set of contracts in the range providing opportunities for solid single-session gains.
$270 Calls – Range: 3.37-6.65 – Max Gain: 97%
$272.50 Calls – Range: 2.77-5.35 – Max Gain: 93%
$275 Calls – Range: 2.52-4.70 – Max Gain: 87%
$277.50 Calls – Range: 1.93-3.85 – Max Gain: 99%
We also could see more bullish activity out of these plays, which we chose to hopefully take advantage of a more extended-term recovery for TSLA.
Fresh Options Ideas:
We’re looking to ABDE on the heels of an earnings neat, and will be after some potential quick-strike gains out of the ADBE Weekly $125 and $130 Calls*.
After trending down a bit over the past week, SNAP has received an analyst downgrade, so we’ll want to radar the SNAP Weekly $20 Puts* today for potential intraday swing trades.
*DO NOT trade weekly options on a Friday unless you’re a highly experienced trader!
POTN, SFOR, ICNB, AREX, ZFGN, BPMX,